Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease.
about
Coagulability in obstructive sleep apneaSuppressive effects of anthrax lethal toxin on megakaryopoiesisDay/Night rhythm of hemostatic factors in obstructive sleep apnea.Sleep and biomarkers of atherosclerosis in elderly Alzheimer caregivers and controls.High-intensity Interval Training Improves Mitochondrial Function and Suppresses Thrombin Generation in Platelets undergoing Hypoxic StressSnoring and the risk of obstructive sleep apnea in patients with pulmonary embolism.Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives.Endothelial function in obstructive sleep apnea.Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome.Obstructive sleep apnoea syndrome: a new paradigm by chronic nocturnal intermittent hypoxia and sleep disruption.Endothelial dysfunction in obstructive sleep apnea.Fibrinolytic activity and platelet function in subjects with obstructive sleep apnoea and a patent foramen ovale: is there an option for prevention of ischaemic stroke?Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea.Obstructive sleep apnea and cardiovascular risk.Heavy snoring is a risk factor for case fatality and poor short-term prognosis after a first acute myocardial infarction.Retinal vascular tortuosity in obstructive sleep apneaObstructive sleep apnea and coronary artery disease: from pathophysiology to clinical implications.Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndromeObstructive sleep apnea, cardiovascular disease, and pulmonary hypertension.Regulation of Hemostasis by the Sympathetic Nervous System: Any Contribution to Coronary Artery Disease?Mechanisms of vascular damage in obstructive sleep apnea.Vascular changes, cardiovascular disease and obstructive sleep apnea.Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis.Morbidities associated with obstructive sleep apnea.Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure.An update on cardiovascular effects of obstructive sleep apnoea syndrome.The additive impact of periodic limb movements during sleep on inflammation in patients with obstructive sleep apnea.Circulating levels of vascular endothelial markers in obstructive sleep apnoea syndrome. Effects of nasal continuous positive airway pressurePatients with venous thromboembolism appear to have higher prevalence of obstructive sleep apnea than the general population.Obstructive sleep apnea increases the risk of bladder pain syndrome/interstitial cystitis: a population-based matched-cohort study.Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension.Association Between Hypercoagulability and Severe Obstructive Sleep Apnea.Obstructive sleep apnea and silent cerebral infarction in hypertensive individuals.Severe brachycephalic obstructive airway syndrome is associated with hypercoagulability in dogs.Importance of laboratory parameters in patients with obstructive sleep apnea and their relationship with cardiovascular diseases.Chronic intermittent asphyxia increases platelet reactivity in rats.Chronic intermittent hypoxia versus continuous hypoxia: Same effects on hemorheology?Hematological Parameters as Predictors of Cardiovascular Disease in Obstructive Sleep Apnea Syndrome Patients.Chronic intermittent hypoxia accelerates coronary microcirculatory dysfunction in insulin-resistant Goto-Kakizaki rats.Obstructive sleep apnea and cardiovascular risk: is metabolic syndrome the link?
P2860
Q26830210-91470B9B-7F73-4894-AADD-C59BA1D2A905Q28396041-7FDBCEDD-E74E-49E4-9F56-DBC31BDCF191Q33700780-E3DD4485-B325-4019-80F4-C246AADF5BC5Q33748728-66331F49-0B3E-4285-A421-0891671EC61AQ33830008-B3EE6751-CB5D-46F1-841A-75112876CA6EQ34021885-FA5C501B-F2F1-4435-A9DC-A566E2D18068Q34697950-79A70E61-135D-497A-A10B-5A09B1868ACFQ35086889-97541BCD-3600-486F-8686-E5192F9EE38CQ35092244-CE484730-921D-4ED2-87AD-306FE0F73305Q35645816-04A50878-F9D4-4357-85D6-0F0C878C3F5BQ35995356-8F5BB698-C6AA-4014-8C83-8F52A2302AD9Q36436224-6449B32E-1CE4-4B73-978C-988698917AD9Q36518032-2C31A5F3-A336-408F-8789-8FBEA6328EB4Q36663716-FDC4BFA9-C3E6-49D7-AC2C-1E3721ADC387Q36741779-E88DA61F-761B-4D03-9B6A-F2401D830840Q36805059-E8123221-C086-41F1-999F-366289DE58F8Q36830894-FD6E7296-9FEC-4A1F-9215-55CD19A8CF0EQ37015491-E3B1DA13-7696-413F-AA01-5133467FF102Q37077161-3E15F05B-07EB-4983-84BA-5103C32D5E92Q37377506-5CCA5589-49E5-4B4F-AB3A-53A9C6B72871Q37809742-24B39860-2AFC-41A9-9952-CBBCEBC09ACFQ37859758-F4BF5963-4D91-4D5A-B16F-3A2DAEE61A12Q38053120-B22DE4E4-B510-40F6-B75E-3C7F50EAE6B2Q38058356-5710CEC3-E1D8-4F5A-966D-41F454B583E7Q38546311-0BCD3117-B2AB-4C5E-9E7C-393BD8897737Q38869072-37359FD6-0668-46AE-A9B5-91328126539DQ39270963-E5A01413-D689-449E-A01C-D2C284F0FBB3Q40624230-856CBF72-69BA-4F8E-A94B-8B1019F60FAFQ44038649-04FD3358-9A28-4CD6-BA97-FFD6C1C5CA3CQ45029242-4E08106D-4DFB-4C8E-8364-5860855E046DQ46710321-4E998CDF-9DED-4695-847B-EE519445CB7BQ47294246-208EF876-82EB-4750-8D76-56EDAD2FB47BQ47718697-42419C26-FCE4-4868-8C4B-9AAE1E9C54E7Q47745132-CA67A87C-FE6B-48CE-98B6-88354D270B6EQ47750235-F177A880-BE5F-4A07-8C55-48DAABB88FE0Q47844740-97A0C5BF-5FE2-4935-B854-3EF62D965726Q47929676-E6ED630A-1AE4-4F91-97F0-A2EE51C51BABQ47953725-563D2937-B829-4596-ACE7-924832B428C1Q48215443-E7327F6A-229A-47CF-952D-97AB9B7ABF90Q48259221-7B91A91B-3402-4B65-A5FA-B58EA9990F88
P2860
Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hemostatic alterations in pati ...... ns for cardiovascular disease.
@ast
Hemostatic alterations in pati ...... ns for cardiovascular disease.
@en
type
label
Hemostatic alterations in pati ...... ns for cardiovascular disease.
@ast
Hemostatic alterations in pati ...... ns for cardiovascular disease.
@en
prefLabel
Hemostatic alterations in pati ...... ns for cardiovascular disease.
@ast
Hemostatic alterations in pati ...... ns for cardiovascular disease.
@en
P356
P1433
P1476
Hemostatic alterations in pati ...... ns for cardiovascular disease.
@en
P2093
Joel E Dimsdale
Roland von Känel
P304
P356
10.1378/CHEST.124.5.1956
P407
P577
2003-11-01T00:00:00Z